arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Septerna, Inc.

SEPN
$38.45 ▼ -1.96 (-4.85%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
15 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Septerna, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield
Revenue Growth 22375.6%
Op. Margin -62.9%
ROIC -4.7%
FCF / Share $-0.49
Trailing P/E
Price / Book 4.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

15-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$26.75M
↑ +22375.6%
Net Income Profit after all expenses
$-8.64M
↑ +59.8%
Operating Margin Operating profit as % of sales
-62.9%
↓ -25.5% 1th
FCF / Share Free cash flow per share
$-0.49
↓ -6.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
35
Returns
32
Cash Quality
6

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 15 quarters